Sino-Agri Leading Biosciences Co.,Ltd

SSE:603970.SS

12.95 (CNY) • At close April 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012
Revenue 10,595.81810,459.62111,698.7758,822.1116,640.9944,342.4653,734.6273,503.4623,398.4253,234.192,875.1082,488.0482,144.799
Cost of Revenue 9,847.4799,688.22810,931.1278,268.8556,107.2433,896.7723,317.5773,084.5332,994.8632,836.7792,517.3382,199.9571,929.866
Gross Profit 748.339771.394767.648553.257533.751445.694417.05418.929403.562397.411357.77288.091214.933
Gross Profit Ratio 0.0710.0740.0660.0630.080.1030.1120.120.1190.1230.1240.1160.1
Reseach & Development Expenses 67.83766.55746.85338.95535.27631.82613.1462.1491.0681.1822.321.7381.375
General & Administrative Expenses 24.0217.76811.73113.86714.4611.64810.58115.13915.70316.30113.52542.92831.017
Selling & Marketing Expenses 126.584243.68223.601181.313171.369165.647181.636210.951216.102207.327176.836151.243102.554
SG&A 150.604261.448235.331195.18185.829177.295192.217226.089231.805223.628190.361194.171133.571
Other Expenses 228.425127.98350.27250.85946.57346.1721.0520.71142.6147.340.35638.2338.344
Operating Expenses 446.866455.988332.457284.994267.679255.293243.045265.097266.614260.232220.744194.412134.051
Operating Income 301.473315.406324.894345.736211.421209.024156.942122.7274.96875.49279.41759.2569.608
Operating Income Ratio 0.0280.030.0280.0390.0320.0480.0420.0350.0220.0230.0280.0240.032
Total Other Income Expenses Net 0.634-0.280.796-105.497-3.961-53.391.0521.01942.05447.29640.35438.1878.335
Income Before Tax 302.108315.126325.69240.239207.46155.634157.993123.739117.445122.789119.77297.43777.943
Income Before Tax Ratio 0.0290.030.0280.0270.0310.0360.0420.0350.0350.0380.0420.0390.036
Income Tax Expense 73.23367.54877.78154.60452.40931.14542.84334.04633.12939.18534.32525.99420.799
Net Income 203.377224.841210.315170.309132.444118.876115.45990.3381.71788.26780.71968.72455.462
Net Income Ratio 0.0190.0210.0180.0190.020.0270.0310.0260.0240.0270.0280.0280.026
EPS 0.760.840.780.630.490.440.430.440.410.440.40.390.34
EPS Diluted 0.760.840.780.630.490.440.430.440.410.440.40.390.34
EBITDA 357.508352.805375.851299.821262.228214.628196.93160.799201.832190.199167.49197.46582.681
EBITDA Ratio 0.0340.0340.0320.0340.0390.0490.0530.0460.0590.0590.0580.0390.039